secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2024-08-21T23:59:59+00:00
Accession:  0001005286-24-000119
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore shareholders approve board declassification, share increase; appoints four new directors
--------------------------------------------------------------------------------

- Shareholders approved phased-in board declassification: 21.6M for, 77K against.
- Authorized common shares increased to 75M from 50M.
- Four new directors appointed: Jason Aryeh, Paul H. Johnson, Humberto C. Antunes, Matthew Korenberg.
- Director Nathaniel Calloway resigned post-meeting; no disagreement cited.
- 2019 Stock Incentive Plan amended: +300K shares available, total 3,059,797 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000119/0001005286-24-000119-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000119/lndc-20240815.htm
  HTML page:      https://secwatch.observer/filing/0001005286-24-000119

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer